Please assess the completion status of the following clinical trial:

Trial Title: To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Actively working, either full-time or part-time~* Previous confirmed diagnosis of PsA by a rheumatologist~* Patients for whom the physician has initiated PsA treatment with an Anti-TNF in accordance with Turkish Ministry of Health regulations and reimbursement criteria~* Able to provide authorization to use and disclose their health related information~Exclusion Criteria:~* Patients with a history of an allergic reaction or significant sensitivity to anti-TNF agents~* Patients with possible follow-up problems during the planned study period or patients who may not be compliant to treatment as evaluated by the investigator/treating physician~* Patients participating in any clinical trial of an experimental drug 30 days prior to the baseline visit

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Participants Receiving Anti-TNF for PsA (Type: None): Participants who are actively working (full-time or part-time) with rheumatologist-confirmed PsA for which the physician has initiated treatment with an anti-TNF.

Based on this trial design, predict the completion outcome and termination type (if applicable).